高能环境: 高能环境关于控股孙公司业绩承诺补偿的进展公告

Core Viewpoint - The company has decided to sell its 51% stake in its subsidiary, High Energy Lijia Medical Technology Co., Ltd., due to unmet performance targets and strategic misalignment, resulting in a cash recovery of approximately RMB 37.27 million [1][3][4]. Group 1: Acquisition and Performance Commitment - The company acquired a 51% stake in High Energy Lijia to extend its industrial chain and achieve a closed-loop resource utilization in the medical recyclable materials sector [1]. - High Energy Lijia has failed to meet its performance targets for two consecutive years, leading to the decision to sell the stake [2][3]. Group 2: Reasons for Share Transfer - The management of High Energy Lijia and the company found it difficult to align on development strategies and operational philosophies, prompting the sale [1][2]. - The sale price for the 51% stake is set at RMB 35.4762 million, and post-sale, High Energy Lijia will no longer be included in the company's consolidated financial statements [1][3]. Group 3: Performance Compensation Agreement - According to the original investment agreement, if High Energy Lijia fails to meet its performance commitments, the shareholder, Chen Ranhui, is obligated to provide cash or equity compensation [2]. - For the fiscal year 2023, High Energy Lijia reported a net profit of RMB 9.2367 million against a target of RMB 10 million, and for 2024, a profit of RMB 14.2802 million against a target of RMB 15 million [2]. Group 4: Impact of the Transaction - The transaction is viewed as a rational adjustment of the company's asset structure, aligning with its long-term strategic planning and alleviating financial burdens [4]. - The company expects that the sale will improve its profitability by divesting from underperforming assets [4]. Group 5: Approval Process - The independent directors and the board of directors approved the performance compensation and share transfer proposal during meetings held on June 11, 2025, with unanimous support [4][5].